Faldaprevir
Faldaprevir was an experimental drug for the treatment of hepatitis C (HCV). It was being developed by Boehringer-Ingelheim and reached Phase III clinical trials in 2011. Boehringer announced in 2014 that it would not pursue approval of the drug any more because of better HCV treatments having become available.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Faldaprevir
Faldaprevir was an experimental drug for the treatment of hepatitis C (HCV). It was being developed by Boehringer-Ingelheim and reached Phase III clinical trials in 2011. Boehringer announced in 2014 that it would not pursue approval of the drug any more because of better HCV treatments having become available.
has abstract
Faldaprevir was an experimenta ...... ments having become available.
@en
CAS number
801283-95-4
ChEMBL
DrugBank
FDA UNII code
958X4J301A
PubChem
Link from a Wikipage to an external page
Wikipage page ID
38,750,476
page length (characters) of wiki page
Wikipage revision ID
1,020,812,496
Link from a Wikipage to another Wikipage
ATC prefix
J05
@en
ATC suffix
AP04
@en
CAS number
ChEMBL
ChemSpiderID
26,327,117
DrugBank
DB11808
@en
IUPAC name
N-[carbonyl]-3-methyl-(L)-valyl--4--N-[-1-carboxy-2-vinylcyclopropyl]-(L)-prolinamide
@en
legal status
Abandoned
@en
PubChem
42,601,552
routes of administration
SMILES
CCCNc1ncc2ccO[C@@H]4C[C@H]CN[C@@]6CO
@en
StdInChIKey
LLGDPTDZOVKFDU-XUHJSTDZSA-N
@en
synonyms
BI 201335
@en
wikiPageUsesTemplate
subject
hypernym
comment
Faldaprevir was an experimenta ...... ments having become available.
@en
label
Faldaprevir
@en